Greenway (GWAY) Swings to Q2 Profit

Greenway Medical Technologies (NYSE: GWAY) reported Q2 EPS of $1.70, versus ($1.01) reported last year. Revenue for the quarter came in at $29.1 million, versus $22.3 million reported last year.

Pro-forma net loss was 1 cent per share.

For earnings history and earnings-related data on Greenway Medical Technologies (GWAY) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Abercrombie & Fitch (ANF) PT Raised to $153 at UBS on Decent Q2, Stable Trend Across Brands
• Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance